Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Why do we celebrate the International Clinical Trials Day?

What happened 271 ago? In May 1747, at a time when scurvy was rampant among sailors, James Lind, a pioneer of naval hygiene, conducted what is now considered to be the very first clinical trial. Lind, a surgeon mate on board HMS Salisbury, recruited twelve men into a study that investigated which acidic substances could cure scurvy (spoiler alert: it was citrus fruits).

Clinical Trials DaySince then, May 20th is widely celebrated as the International Clinical Trials Day. It is an occasion to highlight the importance of clinical trials, raise awareness of participation opportunities and discuss the process of volunteering – and members of Paediatrics’ Oxford Vaccine Group have been on board with the celebrations. Alongside leaflets and stickers, Annabel Coxon and Rebecca Beckley brought in a set of Lego people, which helped to explain how herd immunity works. The Lego game has been a hit with children and adults alike!

To get involved in the clinical trials run by Paediatrics, visit our recruiting page.

 

 

 

 

 

 

 

 

 

Similar stories

Vaccine for TB receives a $1.5 million funding boost

The Oxford-run VALIDATE Network has received $1.5 million in funding for its tuberculosis vaccine work from the Bill & Melinda Gates Foundation.

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

Oxford Vaccine Group among winners at NHS Parliamentary awards

Researchers behind the Oxford AstraZeneca coronavirus vaccine have been recognised for their excellence at a healthcare awards ceremony.

New book highlights life-saving role vaccines play in prevention of killer diseases

'Brain Fever', a new book by internationally-renowned medical scientist Professor Richard Moxon, describes the decades of research that contribute to the development of vaccines for life-threatening illnesses such as meningitis, and how immunisation has been our greatest public health intervention.

Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study

Alternating doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against COVID-19, according to researchers running the University of Oxford-led Com-COV study.